Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 350996-89-3 | MDL No. : | MFCD01114969 |
Formula : | C8H12N2OS | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | N/A |
M.W : | 184.26 g/mol | Pubchem ID : | - |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 5 |
Fraction Csp3 : | 0.38 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 51.56 |
TPSA : | 97.35 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.09 cm/s |
Log Po/w (iLOGP) : | 1.58 |
Log Po/w (XLOGP3) : | 1.88 |
Log Po/w (WLOGP) : | 1.31 |
Log Po/w (MLOGP) : | 0.57 |
Log Po/w (SILICOS-IT) : | 2.18 |
Consensus Log Po/w : | 1.5 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.34 |
Solubility : | 0.836 mg/ml ; 0.00454 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.55 |
Solubility : | 0.0524 mg/ml ; 0.000284 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.08 |
Solubility : | 1.54 mg/ml ; 0.00838 mol/l |
Class : | Soluble |
PAINS : | 1.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.25 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H319-H302 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
5% | With sulfur; diethylamine In ethanol at 20℃; | 48.a Example 48 4-Ethyl-5-methyl-2-(2-(3-(trifluoromethyl)-4,5,6,7-tetrahvdroindazole-1-yl)acetamido) thiophene-3-carboxamidea) 2-Amino-4-ethyl-5-methylthiophene-3-carboxamide2-pentanone (1.52 g, 17.6 mmol), cyanoacetamide (1.50 g, 17.6 mmol) and sulphur (560 mg, 17.6mmol) were stirred in EtOH (6 ml_). Diethylamine (2 mL, 19.4 mmol) was added and the reaction stirred at RT overnight. Water (20 mL) was added and the precipitate filtered off and washed with heptane (100 mL) to give the product as a cream solid (150 mg, 0.81 mmol, 5 %).1 H NMR (400MHz, CDCI3): δ 1.17 (t, 3H), 2.18 (s, 3H), 2.61 (q,2H), 5.48 (bs,2H), 5.84(bs, 2H). |
With sulfur; diethylamine In ethanol Reflux; |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Stage #1: 2-amino-4-ethyl-5-methylthiophene-3-carboxamide; 2-(3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)acetic acid at 120℃; Microwave irradiation; Stage #2: With trifluoroacetic acid In dichloromethane at 20℃; |